CA2492278A1 - Composition pharmaceutique contenant des analogues de l'acide chlorogenique pouvant servir a traiter la leucemie myeloide chronique - Google Patents

Composition pharmaceutique contenant des analogues de l'acide chlorogenique pouvant servir a traiter la leucemie myeloide chronique Download PDF

Info

Publication number
CA2492278A1
CA2492278A1 CA002492278A CA2492278A CA2492278A1 CA 2492278 A1 CA2492278 A1 CA 2492278A1 CA 002492278 A CA002492278 A CA 002492278A CA 2492278 A CA2492278 A CA 2492278A CA 2492278 A1 CA2492278 A1 CA 2492278A1
Authority
CA
Canada
Prior art keywords
composition
acid
cells
chlorogenic acid
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002492278A
Other languages
English (en)
Inventor
Santu Bandyopadhyay
Bikash Chandra Pal
Samir Bhattacharya
Kesheb Chandra Roy
Gautam Bandyopadhyay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/IB2003/000044 external-priority patent/WO2004004708A1/fr
Publication of CA2492278A1 publication Critical patent/CA2492278A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une composition pharmaceutique destinée à traiter la leucémie myéloïde chronique dans laquelle la Bcr-Abl kinase est exprimée de manière constitutive chez l'animal et chez l'homme. Cette composition comprend une quantité efficace d'analogues de l'acide chlorogénique tel que l'acide néochlorogénique (acide 5-O-caffeoyl quinique), l'acide cryptochlorogénique (acide 4-O-caffeoyl quinique), l'acide 3-O-(3'-méthylcaffeoyl) quinique et l'acide 5-O-(caffeoyl-4'-méthyl) quinique et/ou leurs sels tels que sodium, potassium and ammonium, ainsi que des additifs pharmaceutiquement acceptables.
CA002492278A 2002-07-08 2003-01-10 Composition pharmaceutique contenant des analogues de l'acide chlorogenique pouvant servir a traiter la leucemie myeloide chronique Abandoned CA2492278A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39375002P 2002-07-08 2002-07-08
US60/393,750 2002-07-08
US38416303P 2003-01-09 2003-01-09
US60/384,163 2003-01-09
PCT/IB2003/000044 WO2004004708A1 (fr) 2002-07-08 2003-01-10 Composition pharmaceutique utile dans le traitement de la leucemie myeloide chronique

Publications (1)

Publication Number Publication Date
CA2492278A1 true CA2492278A1 (fr) 2004-01-15

Family

ID=34380793

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002492278A Abandoned CA2492278A1 (fr) 2002-07-08 2003-01-10 Composition pharmaceutique contenant des analogues de l'acide chlorogenique pouvant servir a traiter la leucemie myeloide chronique

Country Status (2)

Country Link
CN (1) CN1678300A (fr)
CA (1) CA2492278A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113801021A (zh) * 2020-06-12 2021-12-17 北京科莱博医药开发有限责任公司 绿原酸钠水合物及其应用

Also Published As

Publication number Publication date
CN1678300A (zh) 2005-10-05

Similar Documents

Publication Publication Date Title
Chen et al. Antitumor activity of Annona squamosa seed oil
RU2314096C2 (ru) Синергическая фармацевтическая композиция для лечения лейкемии
KR20190098649A (ko) 칸나비디올 추출물을 함유하는 대장암 예방 또는 치료용 약학 조성물
CN111356468A (zh) 包含黃漆木提取物作为有效成分的用于预防或治疗纤维化疾病的组合物
JPH1067656A (ja) 細胞接着抑制剤
Deng et al. Synthesis and biological evaluation of novel schisanhenol derivatives as potential hepatoprotective agents
US20070161704A1 (en) Pharmaceutical composition useful for treating chronic myeloid leukemia
WO2004004708A9 (fr) Composition pharmaceutique utile dans le traitement de la leucemie myeloide chronique
US20040006138A1 (en) Pharmaceutical composition useful for treating chronic myeloid leukemia
US20050282892A1 (en) Pharmaceutical composition useful for treating chronic myeloid leukemia
KR20050078743A (ko) 로즈마린산의 하이드록실페닐 유도체를 유효성분으로 하는항암용 약학 조성물
US8580847B2 (en) Antrocin containing pharmaceutical compositions for inhibiting cancer cells
CA3108483A1 (fr) Compositions et procedes permettant d'induire l'apoptose dans des cellules anaerobies et procedes cliniques associes pour le traitement du cancer et d'infections pathogenes
CA2492278A1 (fr) Composition pharmaceutique contenant des analogues de l'acide chlorogenique pouvant servir a traiter la leucemie myeloide chronique
US11957699B2 (en) Composition comprising punicalagin for inhibiting PAR2 activity
CN105712982B (zh) 二氢-β-沉香呋喃型倍半萜类化合物、其制法和用途
US20050175623A1 (en) Saponins as anticancer agent
KR100697235B1 (ko) 관동화 추출물 또는 투실라곤을 포함하는 비만 및 제2형당뇨병 예방 및 치료용 조성물
KR100191901B1 (ko) 새로운 세스퀴테르펜 에스테르 화합물
Pettit et al. Biosynthetic products for anticancer drug design and treatment: The Bryostatins
KR20050018972A (ko) 만성 골수성 백혈병을 치료하는데 유용한 약학 조성물
JP2003113088A (ja) 発ガンプロモーター抑制剤及びそれを含有する組成物
CN112870193B (zh) 褪黑素在制备治疗对靶向药物耐药的her2阳性乳腺癌的药物中的应用
Onyeaghala et al. Chemical isolation and characterization of a popular detoxifying herbal remedy yoyo bitters (yyb) using gc-ms, nmr and ftir analysis
TWI465241B (zh) 圓柏（Ｊｕｎｉｐｅｒｕｓ ｃｈｉｎｅｎｓｉｓ）萃取物或木酚素（ｌｉｇｎａｎ）用於製造抑制血管新生之藥物的用途

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued